DIANA HUCKABY: Open Payments
NPI 1902355977 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,660 in 286 payments from 34 companies in 2025. Trend: 2023 $4,418 · 2024 $4,852 · 2025 $4,660
Food & beverage: $4,660
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 23 | $422 |
| Novo Nordisk Inc | 20 | $392 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 20 | $360 |
| Ascensia Diabetes Care Us Inc. | 34 | $328 |
| Amgen Inc. | 20 | $287 |
| Sequel Med Tech, LLC | 35 | $269 |
| Corcept Therapeutics | 12 | $254 |
| KYOWA KIRIN, INC. | 10 | $237 |
| Mannkind Corporation | 17 | $211 |
| Abbott Laboratories | 13 | $191 |
Products named: JARDIANCE, TWIIST, Korlym, CRYSVITA, AFREZZA, FREESTYLE LIBRE 3, MOUNJARO, TZIELD.
Industry payments across TX — which companies pay providers there.
